Open AccessSUN-348 Cabozantinib in Advanced Adrenocortical Carcinoma: Rationale and Protocol of Two Phase II Clinical Trials
Author(s) -
Matthias Kroiß,
Maria-Elisabeth Goebeler,
Camilo Jiménez,
Uwe Malzahn,
Martin Fassnacht,
Mouhammed Amir Habra
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sun-348
Subject(s) - cabozantinib , mitotane , medicine , adrenocortical carcinoma , discontinuation , clinical endpoint , oncology , clinical trial , sunitinib , adverse effect , cancer , pharmacology , cancer research